Back to homepage

Tag "Subject Experts Committee"

DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster

DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster

🕔13:15, 5.Jan 2022

New Delhi, Jan 5 (IANS) The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted “in principle” approval to Bharat Biotech to conduct “Phase III superiority study and Phase III booster dose study” trials for

Read Full Article